2023 Report Shows Biohealth Impact in WI
In 2023, the biohealth industry in Wisconsin contributed $22 billion in economic output and $37.7 billion in total economic impact in the state, combining direct, indirect and induced sources, according…
Category Archives: Biotech
SHINE Collaborates With UW, WARF on Treatments
SHINE Technologies and WARF Therapeutics today announced pre-clinical research results from collaborative efforts with the Advanced Radiotheranostics Lab at the University of Wisconsin. According to a release, the studies showed…
Exact Sciences Earns FDA Approval for Cologuard Plus
Exact Sciences announced today that the U.S. Food and Drug Administration (FDA) approved its next-generation multitarget stool DNA test called Cologuard Plus. “Cologuard Plus sets a new performance standard in…
Voximetry Receives $2M NIH Grant
Voximetry received a $2 million grant from the U.S. Cancer Institute, part of the National Institutes of Health, to enhance the efficiency and accuracy of conventional nuclear medicine SPECT/CT imaging,…
SHINE Receives 2nd DOE Grant
SHINE Technologies was awarded another Department of Energy’s Small Business Innovation Research Grant to help transform DOE-supported science and technology breakthroughs into viable products and services, creating a bridge between…
SHINE, GlyTherix to Partner
SHINE Technologies announced recently that it is entering into a supply agreement with GlyTherix Ltd, an Australian targeted-radiotherapy company specializing in developing antibody radiopharmaceuticals for solid tumors. According to a…
Exact Sciences Gives Report on Blood-Based Test
Exact Sciences announced performance data for its blood-based colorectal cancer (CRC) screening test at the European Society of Medical Oncology (ESMO) Congress, the company announced recently. According to a release,…
Invenra Granted RPDD, ODD by FDA
Invenra announced today that the U.S. Food and Drug Administration has granted Rare Pediatric Disease Designation (RPDD) and Orphan Drug Designations (ODD) to its innovative bispecific antibody, INV724, developed for…
BioForward Announces 2024 Award Recipients
BioForward announced recently the recipients of its 10th annual Wisconsin Biohealth Awards, which recognize exceptional scientific and business accomplishments within the state’s biohealth industry. Dr. Cecilia Hillard, professor of pharmacology…
Exact Sciences Reports First Patient in Falcon Registry Study
Exact Sciences enrolled its first patient in its Multi-Cancer Early Detection (MCED) Falcon Registry Real-World Evidence Study, the company announced today. According to a release, the study will evaluate the…
